The AHNAK2 Knockout Jurkat Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population derived from the immortalized human T lymphocyte Jurkat cell line. This product provides a loss-of-function model for the AHNAK2 gene, generated through CRISPR/Cas9-mediated gene disruption, resulting in a heterogeneous pool of edited cells. The polyclonal format is suitable for studying gene function without isolating single-cell clones, allowing researchers to assess population-level effects on T cell biology, signaling, and migration.
The Jurkat host cell line is an established model originating from an acute T cell leukemia patient and is widely employed to investigate T cell receptor signaling, immune activation, and lymphocytic malignancies. These cells exhibit constitutive activation of T cell signaling pathways and are amenable to genetic manipulation, making them an ideal basis for knockout studies. The AHNAK2 Knockout Jurkat Polyclonal Cells retain the key characteristics of the parental line while enabling targeted interrogation of scaffold protein contributions to lymphocyte function.
AHNAK2 encodes a large scaffold protein that plays a pivotal role in regulating cell adhesion, migration, and epithelial?Cmesenchymal transition by integrating signals from the TGF-beta pathway and calcium influx. AHNAK2 is activated downstream of TGF-beta and calcium signaling, and it interacts with the actin cytoskeleton, S100A10, and calcium channels of the TRP family. This scaffold orchestrates cytoskeletal remodeling, promotes downregulation of E-cadherin, and upregulates mesenchymal markers. Representative pathway components include TGFB1, SMAD3, and ACTB, which link AHNAK2 to transcriptional reprogramming and dynamic actin reorganization.
In the Jurkat T cell context, AHNAK2 disruption is likely to perturb calcium-dependent signaling cascades and cytoskeletal rearrangements essential for T cell migration and activation. Since Jurkat cells serve as a model for immune response and leukemia, this knockout model offers a unique tool to dissect how AHNAK2-mediated scaffold functions influence lymphocyte motility, adhesion, and signal integration. Studies with these cells may reveal mechanistic insights into how AHNAK2 loss impacts T cell behavior relevant to immune surveillance and hematological malignancies.
Researchers can apply these polyclonal knockout cells in diverse experimental workflows, including calcium imaging to monitor intracellular flux, migration and adhesion assays to quantify cell motility, western blotting and immunofluorescence to validate protein expression and localization, and flow cytometry to measure activation markers. These applications support investigations into T cell migration, calcium signaling in lymphocytes, EMT-like processes in leukemia, and cancer cell metastasis mechanisms. For further technical details or custom inquiries, please contact Ascent Research.
